{"id":"W1999594000","doi":"10.1056/nejme1408614","title":"Anti–Interleukin-5 Monoclonal Antibody to Treat Severe Eosinophilic Asthma","year":2014,"lang":"en","type":"letter","venue":"New England Journal of Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Mepolizumab; Asthma; Monoclonal antibody; Omalizumab; Immunology; Disease; Eosinophilic; Airway hyperresponsiveness; Airway; Quality of life (healthcare); Monoclonal; Immunoglobulin E; Intensive care medicine; Antibody; Eosinophil; Internal medicine; Anesthesia; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005494549,0.0006050928,0.0006343217,0.0005560001,0.0009802454,0.0006495799,0.0007907331,0.009171372,0.004719892],"category_scores_gemma":[0.003132978,0.0002624637,0.0006977624,0.0002952385,0.0007826464,0.001087894,0.0003461838,0.00881325,0.004801],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001480977,"about_ca_system_score_gemma":0.0007268023,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001187056,"about_ca_topic_score_gemma":0.002586703,"domain_scores_codex":[0.9994451,0.0001871638,0.00004903484,0.00005050701,0.0001932435,0.00007489038],"domain_scores_gemma":[0.9995325,0.0002210277,0.00004075167,0.00002153999,0.00009394278,0.00009031512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002783927,0.0005566003,0.003598176,0.0003171498,0.00006938987,0.06014059,0.0001187814,0.0004949689,0.002577011,0.004646046,0.8494629,0.07773986],"study_design_scores_gemma":[0.0008891581,0.0009067478,0.00925443,0.001082917,0.00008438792,0.1132836,0.0001852231,0.002095893,0.001419597,0.009590716,0.8611325,0.0000747644],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.009288037,0.02294298,0.001015543,0.8877245,0.03510308,0.0001695208,0.0001179715,0.0002025932,0.04343576],"genre_scores_gemma":[0.075417,0.02162095,0.001992407,0.7594436,0.09806247,0.0001811713,0.0001870581,0.00005270519,0.0430426],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.009171372,"threshold_uncertainty_score":0.01578957,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01764172784304591,"score_gpt":0.2951232874988206,"score_spread":0.2774815596557747,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}